VA SAN diego pharmacy service is requesting a sole source procurement from alliancerx walgreens specialty pharmacy, a sole distributor for tolvaptan (jynarque).
Ended Awarded Last action
- Contract number
- 36C26223F0023
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $155,724
Award facts
- Contract value 100% obligated
- $155,724.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $18,616 | |
| Original award | $137,108 |
About this award
The Department of Veterans Affairs (VA) San Diego Pharmacy Service awarded a delivery order valued at $155,724.16 to Otsuka America Pharmaceutical Inc. for the sole-source procurement of Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This firm-fixed-price contract, awarded on October 4, 2022, with an ultimate completion date of September 30, 2023, was issued without a set-aside designation under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The sole-source justification reflects Otsuka America Pharmaceutical Inc.'s exclusive distributor status for this critical medication through its partnership with AllianceRx Walgreens Specialty Pharmacy, with performance to occur in Pittsburgh, Pennsylvania.
This delivery order is issued under Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement with the VA's National Acquisition Center, valued at approximately $83.3 million through March 2026, which enables Veterans Integrated Service Networks nationwide to efficiently procure Jynarque and other specialty pharmaceuticals. The contractor's established Federal Supply Schedule contract portfolio exceeding $396 million demonstrates its significant capability to supply federal healthcare systems. This procurement supports the VA's Veterans Health Administration mission of providing specialized pharmaceutical treatments to veterans across multiple integrated service networks, including VISN 22.
Quick answers
Who was awarded contract 36C26223F0023?
36C26223F0023 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 4, 2022.
How much is contract 36C26223F0023 worth?
The government has obligated $155,724 on 36C26223F0023.
Is contract 36C26223F0023 an order under another contract?
Yes. 36C26223F0023 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26223F0023 competed?
The extent of competition for 36C26223F0023 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award